智通财经APP讯，漱玉平民(301017.SZ)发布公告，持股5%以上股东阿里健康科技(中国)有限公司(以下 简称"阿里健康")计划在本公告发布之日起15个交易日后的3个月内(即2026年2月4日至2026年4月30日)， 以集中竞价和/或大宗交易方式共计减持公司股份不超过810.72万股，占公司总股本的2%。 ...

Group 1 - The core point of the article is that Alibaba Health Technology (China) Co., Ltd. plans to reduce its stake in Shuyu Pingmin Pharmacy Chain Co., Ltd. by selling up to approximately 8.11 million shares, which represents 2% of the company's total share capital [1] Group 2 - Alibaba Health currently holds about 27.04 million shares in Shuyu Pingmin, accounting for 6.67% of the total share capital [1] - The share reduction will take place within three months after the announcement, starting 15 trading days from the date of the announcement [1]

漱玉平民（301017）(301017.SZ)发布公告，持股5%以上股东阿里健康科技(中国)有限公司(以下简称"阿 里健康")计划在本公告发布之日起15个交易日后的3个月内(即2026年2月4日至2026年4月30日)，以集中 竞价和/或大宗交易方式共计减持公司股份不超过810.72万股，占公司总股本的2%。 ...

漱玉平民公告，持股5%以上股东阿里健康持有公司2703.91万股，占6.67%，计划自本公告披露15个交 易日后的2026年2月4日至2026年4月30日，通过集中竞价和/或大宗交易合计减持不超810.72万股，占公 司总股本2%。其中集中竞价不超405.36万股，占1%，大宗交易不超405.36万股，占1%；减持原因为自 身资金需求，股份来源为首次公开发行前取得的股份。 ...

| 证券代码：301017 | 证券简称：漱玉平民 | 公告编号：2026-002 | | --- | --- | --- | | 债券代码：123172 | 债券简称：漱玉转债 | | 漱玉平民大药房连锁股份有限公司 特别提示 1、漱玉平民大药房连锁股份有限公司（以下简称"公司"或"发行人"）持股 5%以上 股东阿里健康科技(中国)有限公司（以下简称"阿里健康"）持有公司股份 27,039,100 股 （占公司总股本比例为 6.67%），计划在本公告发布之日起 15 个交易日后的 3 个月内（即 2026 年 2 月 4 日至 2026 年 4 月 30 日），以集中竞价和/或大宗交易方式共计减持本公司股 份不超过 8,107,214 股，占公司总股本的 2%。 公司于近日收到公司持股 5%以上股东阿里健康出具的《关于股份减持计划的意向函》， 根据《深圳证券交易所上市公司自律监管指引第 18 号——股东及董事、高级管理人员减持 股份》等相关法律法规的规定，现将具体情况公告如下： | 一、股东基本情况 | | --- | | 股东名称 | | 股东身份 | 持股数量（股） | 占公司总股本的比例（%） | | ...

Group 1 - The pharmaceutical commercial sector increased by 1.21% on January 13, with Shuyupingmin leading the gains [1] - The Shanghai Composite Index closed at 4138.76, down 0.64%, while the Shenzhen Component Index closed at 14169.4, down 1.37% [1] - Notable gainers in the pharmaceutical sector included Shuyupingmin, which rose by 10.15% to a closing price of 19.43, and Ruikang Pharmaceutical, which increased by 10.06% to 3.83 [1] Group 2 - The pharmaceutical commercial sector saw a net inflow of 395 million yuan from main funds, while retail investors experienced a net outflow of 215 million yuan [2] - Major stocks with significant net inflows included Haiwang Biological with 220 million yuan and Huaren Health with 165 million yuan [3] - Conversely, retail investors showed notable outflows in stocks like Ruikang Pharmaceutical and Huaren Health, with outflows of 121 million yuan and 67.99 million yuan respectively [3]

Market Performance - The pharmaceutical commercial sector increased by 0.8% on January 12, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 4165.29, up 1.09%, while the Shenzhen Component Index closed at 14366.91, up 1.75% [1] Top Gainers - RunDa Medical (603108) closed at 19.47, up 8.53%, with a trading volume of 1.0956 million shares and a transaction value of 2.123 billion [1] - Jia Shi Tang (002462) closed at 17.13, up 6.33%, with a trading volume of 441,200 shares and a transaction value of 733 million [1] - Yao Yi Gou (300937) closed at 38.42, up 4.54%, with a trading volume of 127,500 shares and a transaction value of 480 million [1] Top Losers - Nanjing Pharmaceutical (600713) closed at 5.43, down 1.63%, with a trading volume of 284,200 shares and a transaction value of 154 million [2] - Zhong Yao Holdings (000950) closed at 6.24, down 1.11%, with a trading volume of 740,900 shares and a transaction value of 461 million [2] - Ying Te Group (000411) closed at 12.81, down 1.08%, with a trading volume of 187,000 shares and a transaction value of 239 million [2] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 234 million from institutional investors and 184 million from speculative funds, while retail investors saw a net inflow of 417 million [2] - RunDa Medical had a net inflow of 123 million from institutional investors, but a net outflow of 171 million from speculative funds [3] - Jia Shi Tang experienced a net inflow of 80.845 million from institutional investors, with a net outflow of 28.7836 million from speculative funds [3]

Market Performance - The pharmaceutical commercial sector increased by 1.32% on January 9, with RunDa Medical leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Top Gainers - RunDa Medical (603108) closed at 17.94, up 9.99% with a trading volume of 846,200 shares [1] - Huaren Health (301408) closed at 22.17, up 9.97% with a trading volume of 627,800 shares [1] - Shangyu Pingmin (301017) closed at 17.24, up 7.75% with a trading volume of 336,500 shares [1] Other Notable Stocks - Zhongyao Holdings (000950) closed at 6.31, up 5.87% with a trading volume of 1,147,000 shares [1] - Saily Medical (603716) closed at 27.83, up 4.39% with a trading volume of 783,100 shares [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 122 million yuan from institutional investors and 174 million yuan from speculative funds, while retail investors saw a net inflow of 296 million yuan [2] - The trading volume and turnover for various stocks indicate a mixed sentiment among different investor categories [2] Individual Stock Fund Flow - RunDa Medical had a net inflow of 2.30 billion yuan from institutional investors, while it faced a net outflow of 1.36 billion yuan from speculative funds [3] - Zhongyao Holdings saw a net inflow of 61.04 million yuan from institutional investors, with a net outflow of 62.93 million yuan from retail investors [3] - The overall fund flow indicates varying levels of confidence among different investor types in the pharmaceutical sector [3]

Market Overview - The pharmaceutical commercial sector increased by 0.79% compared to the previous trading day, with Luyuan Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4082.98, down 0.07%, while the Shenzhen Component Index closed at 13959.48, down 0.51% [1] Top Gainers in Pharmaceutical Sector - Luyuan Pharmaceutical (002788) closed at 27.49, up 10.00% with a trading volume of 812,100 shares and a transaction value of 2.156 billion [1] - Saili Medical (603716) closed at 26.66, up 9.98% with a trading volume of 700,200 shares and a transaction value of 1.802 billion [1] - Dajia Weikang (301126) closed at 13.50, up 5.47% with a trading volume of 184,200 shares and a transaction value of 245 million [1] Other Notable Stocks - Run Da Medical (603108) closed at 16.31, up 5.23% with a trading volume of 378,400 shares and a transaction value of 614 million [1] - Huaren Health (301408) closed at 20.16, up 3.38% with a trading volume of 503,400 shares and a transaction value of 1.016 billion [1] Market Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 94.4079 million from institutional investors, while retail investors saw a net inflow of 213 million [2] - The overall market showed a mixed trend with some stocks experiencing significant outflows from institutional and speculative funds [2] Individual Stock Fund Flow - Saili Medical (603716) had a net inflow of 304 million from institutional investors, but a net outflow of 108 million from speculative funds [3] - Run Da Medical (603108) saw a net inflow of 62.5499 million from institutional investors, while experiencing outflows from both speculative and retail investors [3] - Huaren Health (301408) had a net inflow of 41.8956 million from institutional investors, but a significant outflow of 64.016 million from retail investors [3]

东兴证券股份有限公司 关于漱玉平民大药房连锁股份有限公司 2025 年度现场检查报告 保荐机构名称：东兴证券股份有限公司 被保荐公司简称：漱玉平民 保荐代表人姓名：胡杰畏 联系电话：010-66555253 保荐代表人姓名：邹成凤 联系电话：010-66555253 现场检查人员姓名：胡杰畏、李晓科 现场检查对应期间：2025 年度 现场检查时间：2025 年 12 月 25 日至 12 月 26 日 一、现场检查事项 现场检查意见 （一）公司治理 是 否 不适用 现场检查手段：查阅公司章程和现行内部控制制度、治理规则等文件，检查公司三会会议文件、董 事会专业委员会文件；核查公司是否存在同业竞争和影响独立性等情形，查阅公司相关公告及定期报告 等。 1.公司章程和公司治理制度是否完备、合规 √ 2.公司章程和三会规则是否得到有效执行 √ 3.三会会议记录是否完整，时间、地点、出席人员及会议 内容等要件是否齐备，会议资料是否保存完整 √ 4.三会会议决议是否由出席会议的相关人员签名确认 √ 5.公司董监高是否按照有关法律、行政法规、部门规章、 规范性文件和本所相关业务规则履行职责 √ 6.公司董监高如发生重大变化 ...